A large Arizona-based infusion provider with 19 outpatient centers and physician practice partnerships offers therapy for complex chronic conditions through both clinic-based and fully managed practice models. To improve turnaround time and operational efficiency in their eligibility, verification and prior authorization (EVPA) process, they partnered with Prochant to address:
- Manual, spreadsheet-based workflows and limited task visibility
- Delayed authorizations due to fragmented tracking systems
- Inability to measure or manage EVPA turnaround time (TAT) consistently
- Errors and delays caused by toggling between multiple tools
By implementing Prochant Pulse, Prochant’s proprietary technology, and leveraging the expertise of Prochant’s dedicated EVPA team, the partnership delivered measurable improvements within six months:
- 17% Improvement in meeting industry benchmark EVPA TAT in the first month
- EVPA measurability increased from under 60% to over 90%
- 100% audit coverage through embedded QA workflows
Through automation, real-time dashboards and integrated workflows, the client achieved faster authorizations, greater transparency and scalable operations, ensuring patients receive timely treatment and payers receive timely, accurate claims.
Discover how this growing infusion network transformed its EVPA process with Prochant’s tech-enabled solutions and expert-driven support. Fill out the form below to read the full case study.
Frequently Asked Questions
1️⃣ What is EVPA in infusion pharmacy and why is it important?
EVPA stands for Eligibility, Verification, and Prior Authorization. In infusion pharmacy, EVPA ensures that patients meet insurance requirements before starting treatment, reducing claim denials and delays in care. A streamlined EVPA process is critical for timely authorizations, accurate billing, and improving patient outcomes.
2️⃣ How can technology improve EVPA turnaround time (TAT) for infusion providers?
Technology like Prochant Pulse helps infusion providers improve EVPA TAT by automating tasks, integrating workflows, and providing real-time dashboards. This leads to faster authorizations, fewer errors, and better visibility into performance metrics.
3️⃣ What are common challenges infusion providers face with EVPA processes?
Infusion providers often struggle with manual workflows, fragmented tracking systems, inconsistent turnaround times, and lack of transparency. These challenges can delay authorizations, disrupt patient care, and create billing inefficiencies.
4️⃣ How does Prochant help infusion providers streamline EVPA?
Prochant helps infusion providers by combining proprietary technology (Prochant Pulse) with a dedicated EVPA team. This partnership enables automation, quality assurance, and data-driven insights that improve authorization speed, accuracy, and scalability.
5️⃣ Why is it critical for infusion providers to improve EVPA measurability?
Improving EVPA measurability helps infusion providers track and optimize every step of the authorization process. This ensures consistent performance, reduces delays, and enhances payer compliance—ultimately securing timely reimbursement and better patient care.
